• pharma
  • pharmapharma

YOU MIGHT BE INTERESTED IN

  1. World Smoking-Cessation Drug Market 2010-2025

    World Smoking-Cessation Drug Market 2010-2025

    Smoking is a leading cause of preventable death worldwide. In 2009, total sales of smoking-cessation products surpassed $1.6bn (Rx products). The effects of smoking constitute a major burden on public healthcare systems, as well as lowering quality of life for many people. Currently-marketed smoking-cessation products arguably lack the desired levels of efficacy in practice, with the reputation of some suffering through noted side-effects. As a result, there are significant commercial opportunities for more-efficacious and better-tolerated smoking-cessation agents, especially in prescription form.

    ...more details
  2. The Global Anti-Addiction Market, 2008-2023

    The Global Anti-Addiction Market, 2008-2023

    The global addiction market is significantly undervalued. The world's population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents? The brand new report, The Global Anti-Addiction Market, 2008-2023, provides an in-depth analysis of the current state of the market for addiction therapy drugs, from the present looking forward.

    ...more details
  3. The Global OTC Pharmaceutical Market 2009-2024

    The Global OTC Pharmaceutical Market 2009-2024

    General economic trends worldwide will affect the over-the-counter (OTC) pharma market from 2009 onwards, with both market restraints and opportunities present. In this new report visiongain notes that Rx-to-OTC switching and the continuing importance of emerging pharma markets will drive OTC sales growth from 2009 onwards. Our forecasts reveal that the OTC pharma market will grow significantly next decade. This report explains where future OTC switching will occur, providing you with the information that you need to understand the current OTC market and its future prospects. The potential of this market remains significant, despite general economic uncertainty, visiongain asserts.

    ...more details
  4. The Global Vaccines Market 2008-2023

    The Global Vaccines Market 2008-2023

    The key growth driver for vaccines is their cost-effectiveness in combating disease. This situation will encourage greater use of vaccines by governments and private healthcare providers. New disease targets that could be mitigated through vaccination, including high profile (and potentially profitable) targets such as cancer.

    ...more details
  5. World Diabetes Market Analysis, 2009-2023

    World Diabetes Market Analysis, 2009-2023

    Incidence and prevalence of diabetes mellitus are increasing worldwide, in line with lifestyle changes and population aging. In particular, the rising prevalence of diabetes is closely linked with that of obesity, creating significant market opportunities. The World Health Organization estimates the number of diabetics to exceed 350 million by 2030. Governments and other healthcare providers around the world are investing in health education, diagnosis and treatments for this chronic, debilitating - but controllable - disorder.

    ...more details
  6. Global Biotech Market Analysis and Forecasts, 2008-2023

    Global Biotech Market Analysis and Forecasts, 2008-2023

    The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has experienced great expansion since its emergence during the 1970s.

    ...more details

REPORT LICENSES

rss_Pharma.jpg
Smoking Cessation Report, 2009-2024

Smoking Cessation Report, 2009-2024

  • Publication date: 03/02/2009
  • Number of Pages: 125

SINGLE USER

£1499

DEPARTMENTAL (FIVE USERS)

£2999

SITE

£4999

GLOBAL SITE

£6999